Related Experiment Video
Updated: Aug 19, 2026

Isolation of CD133+ Liver Stem Cells for Clonal Expansion
Published on: October 10, 2011
[Inactivation of CDKN2A gene (p16) in gallbladder carcinoma]
Juan Carlos Roa1, Quynh Vo, Juan Carlos Araya
1Departamento de Anatomá Patológica, Universidad de La Frontera, Temuco, Chile. Jcroa@ufro.cl
Background:
The CDKN2A gene encodes a cyclin dependent kinase inhibitor, p16, which promotes cell cycle arrest. Methylation of the promoter region transcriptionally inactivates the gene.
Aim:
To study the relationship between methylation status of the prometer region of p16 gene, the immunohistochemical expression of p16 and clinical and morphological features of gallbladder carcinoma.
Material And Methods:
We analyzed the methylation status of the promoter region of the CDKN2A gene in gallbladder adenocarcinomas using methylation specific PCR (MSP). We also used microsatellite markers near the CDKN2A gene to detect allelic imbalance (AI) and examined the tumors by immunohistochemistry (IHC) for p16 expression.
Results:
Of 38 gallbladder adenocarcinomas analyzed by IHC, 11 cases (29%) were negative for p16 protein. Nine (24%) had methylation of the promoter region of the CDKN2A gene. Twenty nine cases were negative for methylation, but four (14%) of these 29 exhibited AI at one or more of the microsatellite markers. CDKN2A promoter methylation was not associated with microsatellite instability (MSI-H).
Conclusions:
The inactivation of CDKN2A by methylation and/or deletion might play an important role in gallbladder carcinogenesis.
Insights
Promoter methylation and/or deletion of the CDKN2A gene may significantly contribute to gallbladder cancer development. This study investigated CDKN2A gene alterations and p16 expression in gallbladder carcinomas.
Area of Science:
- Molecular biology
- Oncology
- Genetics
Context:
- The CDKN2A gene, encoding p16, is crucial for cell cycle arrest.
- Promoter methylation leads to transcriptional inactivation of CDKN2A.
- Gallbladder carcinoma is a significant health concern with complex molecular underpinnings.
Purpose:
- To investigate the correlation between p16 gene promoter methylation status, p16 protein expression via immunohistochemistry, and the clinical-morphological characteristics of gallbladder carcinoma.
- To elucidate the role of CDKN2A alterations in gallbladder carcinogenesis.
Summary:
- Analysis of 38 gallbladder adenocarcinomas revealed p16 protein negativity in 29% of cases.
- Promoter methylation of CDKN2A was observed in 24% of tumors.
- Allelic imbalance (AI) near CDKN2A was detected in 14% of methylation-negative cases, with no association between CDKN2A promoter methylation and microsatellite instability (MSI-H).
Impact:
- Findings suggest that inactivation of the CDKN2A gene through methylation and/or deletion is implicated in the pathogenesis of gallbladder cancer.
- This research contributes to understanding the molecular mechanisms driving gallbladder carcinogenesis.
- Identifies potential biomarkers for gallbladder carcinoma development.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
